Federated Hermes’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.9K Sell
130
-538,127
-100% -$65.2M ﹤0.01% 1817
2026
Q1
$88M Sell
538,257
-94,041
-15% -$14.5M 0.14% 163
2025
Q4
$110M Buy
632,298
+304,075
+93% +$55.5M 0.18% 133
2025
Q3
$47.3M Buy
328,223
+219,838
+203% +$26.9M 0.08% 284
2025
Q2
$10.9M Sell
108,385
-84,258
-44% -$6.44M 0.02% 552
2025
Q1
$14.7M Sell
192,643
-43,193
-18% -$3.3M 0.03% 469
2024
Q4
$16.3M Buy
235,836
+192,853
+449% +$13.9M 0.04% 449
2024
Q3
$3.14M Buy
42,983
+32,920
+327% +$2.43M 0.01% 831
2024
Q2
$674K Buy
10,063
+9,979
+11,880% +$387K ﹤0.01% 1233
2024
Q1
$2.28K Sell
84
-26
-24% -$728 ﹤0.01% 1908
2023
Q4
$3.41K Sell
110
-16,433
-99% -$426K ﹤0.01% 1889
2023
Q3
$418K Buy
+16,543
New +$378K ﹤0.01% 1391
2019
Q3
Sell
-249,177
Closed -$6.38M 2249
2019
Q2
$6.38M Sell
249,177
-88,793
-26% -$2.47M 0.02% 711
2019
Q1
$9.82M Buy
+337,970
New +$8.76M 0.02% 570
2018
Q2
Sell
-1,016
Closed -$23K 2235
2018
Q1
$23K Sell
1,016
-43,549
-98% -$1.15M ﹤0.01% 1738
2017
Q4
$1.39M Buy
44,565
+28,824
+183% +$851K ﹤0.01% 1095
2017
Q3
$491K Buy
+15,741
New +$300K ﹤0.01% 1374
2017
Q2
Sell
-14,655
Closed -$257K 2152
2017
Q1
$257K Buy
+14,655
New +$226K ﹤0.01% 1462

Other funds holding INSM

Federated Hermes's INSM Position: Q2 2026 in Review

Federated Hermes reduced its Insmed (INSM) stake by 100% in Q2 2026, selling an estimated $65.2M and leaving 130 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Federated Hermes first reported a position in INSM in Q1 2017 and has held it in 18 quarters since. The position peaked at $110M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Federated Hermes held 130 shares of Insmed worth $13.9K as of Q2 2026.
  • Federated Hermes sold 538,127 Insmed shares in Q2 2026, an estimated $65.2M.
  • Insmed made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1817 holding.
  • Federated Hermes first reported a position in Insmed in Q1 2017 and has held it in 18 quarters since.
  • Federated Hermes's Insmed position peaked at $110M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.